Chemical Compound Review:
Gd-DO 3A 2-[4,7- bis(carboxylatomethyl)-1,4,7- triaza...
Synonyms:
This record was replaced with 107830.
- Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Mitchell, D.G., Saini, S., Weinreb, J., De Lange, E.E., Runge, V.M., Kuhlman, J.E., Parisky, Y., Johnson, C.D., Brown, J.J., Schnall, M. Radiology. (1994)
- Phase III multicenter clinical investigation to determine the safety and efficacy of gadoteridol in children suspected of having neurologic disease. Ball, W.S., Nadel, S.N., Zimmerman, R.A., Byrd, S.E., Dietrich, R.B., Prenger, E.C., Drayer, B.P., Nelson, M.D., Morgan, F.W., Altman, N.R. Radiology. (1993)
- Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization? van der Woude, H.J., Verstraete, K.L., Hogendoorn, P.C., Taminiau, A.H., Hermans, J., Bloem, J.L. Radiology. (1998)
- MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. Yuh, W.T., Fisher, D.J., Engelken, J.D., Greene, G.M., Sato, Y., Ryals, T.J., Crain, M.R., Ehrhardt, J.C. Radiology. (1991)
- Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease. Runge, V.M., Bradley, W.G., Brant-Zawadzki, M.N., Carvlin, M.J., DeSimone, D.N., Dean, B.L., Dillon, W.P., Drayer, B.P., Flanders, A.E., Harms, S.E. Radiology. (1991)
- Carotid arteries: maximizing arterial to venous contrast in fluoroscopically triggered contrast-enhanced MR angiography with elliptic centric view ordering. Huston, J., Fain, S.B., Riederer, S.J., Wilman, A.H., Bernstein, M.A., Busse, R.F. Radiology. (1999)
- Fluoroscopically triggered contrast-enhanced three-dimensional MR angiography with elliptical centric view order: application to the renal arteries. Wilman, A.H., Riederer, S.J., King, B.F., Debbins, J.P., Rossman, P.J., Ehman, R.L. Radiology. (1997)
- Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents. Marzola, P., Ramponi, S., Nicolato, E., Lovati, E., Sandri, M., Calderan, L., Crescimanno, C., Merigo, F., Sbarbati, A., Grotti, A., Vultaggio, S., Cavagna, F., Lorusso, V., Osculati, F. Investigative radiology. (2005)
- Acute cardiotoxicity of gadolinium-based contrast media: findings in the isolated rat heart. Akre, B.T., Dunkel, J.A., Hustvedt, S.O., Refsum, H. Academic radiology. (1997)
- MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer. Preda, A., Novikov, V., Möglich, M., Turetschek, K., Shames, D.M., Brasch, R.C., Cavagna, F.M., Roberts, T.P. Journal of magnetic resonance imaging : JMRI. (2004)
- Pharmacokinetic behavior of gadoteridol injection. McLachlan, S.J., Eaton, S., De Simone, D.N. Investigative radiology. (1992)
- Phase III clinical studies with gadoteridol for the evaluation of neurologic pathology. A European perspective. Seiderer, M. Investigative radiology. (1992)
- A multi-organ, axially distributed model of capillary permeability for a magnetic resonance imaging contrast agent. Eaton, S.M., Wedeking, P., Tweedle, M.F., Eckelman, W.C. Journal of pharmaceutical sciences. (1993)
- Summary of preclinical safety evaluation of gadoteridol injection. Soltys, R.A. Investigative radiology. (1992)
- Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Saito, R., Krauze, M.T., Bringas, J.R., Noble, C., McKnight, T.R., Jackson, P., Wendland, M.F., Mamot, C., Drummond, D.C., Kirpotin, D.B., Hong, K., Berger, M.S., Park, J.W., Bankiewicz, K.S. Exp. Neurol. (2005)
- Diffusion into human intervertebral disks studied with MR and gadoteridol. Akansel, G., Haughton, V.M., Papke, R.A., Censky, S. AJNR. American journal of neuroradiology. (1997)
- Usefulness of magnetic resonance imaging early after acute myocardial infarction. Kramer, C.M., Rogers, W.J., Geskin, G., Power, T.P., Theobald, T.M., Hu, Y.L., Reichek, N. Am. J. Cardiol. (1997)
- Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy. Gibby, W.A., Gibby, K.A., Gibby, W.A. Investigative radiology. (2004)
- Enhancement of cerebral diseases: how much contrast agent is enough? Comparison of 0.1, 0.2, and 0.3 mmol/kg gadoteridol at 0.2 T with 0.1 mmol/kg gadoteridol at 1.5 T. Brekenfeld, C., Foert, E., Hundt, W., Kenn, W., Lodeann, K.P., Gehl, H.B. Investigative radiology. (2001)
- Indirect MR lymphangiography of the head and neck using conventional gadolinium contrast: A pilot study in humans. Loo, B.W., Draney, M.T., Sivanandan, R., Ruehm, S.G., Pawlicki, T., Xing, L., Herfkens, R.J., Le, Q.T. Int. J. Radiat. Oncol. Biol. Phys. (2006)
- Comparison of aerosolized gadoteridol and gadopentetate dimeglumine for magnetic resonance ventilation imaging of the lung. Haage, P., Karaagac, S., Adam, G., Glowinski, A., Günther, R.W. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. (2001)
- A noninvasive method for monitoring renal status at bedside. Tweedle, M.F., Zhang, X., Fernandez, M., Wedeking, P., Nunn, A.D., Strauss, H.W. Investigative radiology. (1997)
- Advantages of an increased dose of MRI contrast agent for enhancing inflammatory synovium. Oliver, C., Speake, S., Watt, I., Dieppe, P., Ratcliffe, G. Clinical radiology. (1996)
- Evaluation of Gd-enhancement in brain MR of multiple sclerosis: image subtraction with and without magnetization transfer. Sardanelli, F., Losacco, C., Iozzelli, A., Renzetti, P., Rosso, E., Parodi, R.C., Bonetti, M., Murialdo, A. European radiology. (2002)
- MR arthrography of the glenohumeral joint: two concentrations of gadoteridol versus Ringer solution as the intraarticular contrast material. Binkert, C.A., Zanetti, M., Gerber, C., Hodler, J. Radiology. (2001)
- Multislice first-pass myocardial perfusion imaging on a conventional clinical scanner. Walsh, E.G., Doyle, M., Lawson, M.A., Blackwell, G.G., Pohost, G.M. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. (1995)
- Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation. Levin, J.M., Kaufman, M.J., Ross, M.H., Mendelson, J.H., Maas, L.C., Cohen, B.M., Renshaw, P.F. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. (1995)
- Three-dimensional MR pulmonary perfusion imaging and angiography with an injection of a new blood pool contrast agent B-22956/1. Zheng, J., Carr, J., Harris, K., Saker, M.B., Cavagna, F.M., Maggioni, F., Laub, G., Li, D., Finn, J.P. Journal of magnetic resonance imaging : JMRI. (2001)